Pretreatment HDL‐C and ApoA1 are predictive biomarkers of progression‐free survival in patients with EGFR mutated advanced non‐small cell lung cancer treated with TKI. - Ma, Juan; Bai, Ying; Liu, Mei; Jiao, Tong; Chen, Yang; Yuan, Bo; Liu, Boxuan; Zeng, Lizhong; Ming, Zongjuan; Li, Wei; Sun, Ruiying; Yang, Xia; et al. (Thoracic Cancer, 2022)